PDF herunterladen
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2006; 27(04): 4-6
DOI: 10.1055/s-0041-1733183
Editorial

Advances in the Management of Hodgkin’s Lymphoma

Lalit Kumar
Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi - 110029, India
› Institutsangaben
› Weitere Informationen
  als PDF herunterladen Lizenzen und Reprints


Publikationsverlauf

Artikel online veröffentlicht:
23. März 2022

© 2006. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 DeVita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 1970;73:881-95.
  • 2 Bonadonna G, Zucali R, Monfardini S, De lena M, Uslenghi C. Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 1975;36:252-9.
  • 3 Chandi L, Kumar L, Kochupillai V, Dawar R and Singh R. Hodgkin’s disease : A retrospective analysis of 15 years experience at a large referral centre. Nat Med Jn 1998;11:212-17.
  • 4 Kumar R, Maillard I, Schuster SJ and Alavi A. Utility of fluorodeoxyglucose–PET imaging in the management of patients with Hodgkin’s and non Hodgkin’s lymphoma. Radiol Clin North Am. 2004;42:1083-1100.
  • 5 Yahalom J. Early stage Hodgkin’s lymphoma in Educational Book Pub : Am Soc Clin Oncol , Ed. Perry MC. 2004;40:368-75.
  • 6 Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease N Engl J Med. 1998;3391506-1514.
  • 7 Connors JM, Klimo P, Adams G, Burns BF, Cooper I, Meyer RM, et al. Treatment of advanced Hodgkin’s disease with chemotherapy-comparison of MOPP/ABV hybrid regimen with a alternating courses of MOPP and ABVD: A report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1997;15:1638-45.
  • 8 Duggan DB, Petroni GR, Johnson JL, et al. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin’s disease: report of an intergroup trial. J Clin Oncol. 2003;15:21(4):607-14.
  • 9 Horning SJ, Hoppe RT, Breslin S, et al. Stanford V and radiotherapy for bulky extensive and advanced Hodgkin’s disease : Mature results of a prospective clinical trial. J Clin Oncol 2002;20:630-37.
  • 10 Gobbi, PG, Broglia, C, Levis, A, et al. MOPPEBVCAD Chemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin’s Lymphoma: 10- Year Results, Late Toxicity, and Second Tumours. Clin. Cancer Res., 2006;12(2):529–535
  • 11 Ferme C, Mounier N, Casasnovas O et al. Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte (GELA). Blood. 2006;107(12):4636-42.
  • 12 Johnson PW, Radford JA, Cullen MH et al. Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin’s lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). J Clin Oncol. 2005;23(36):9208-18.
  • 13 Diehl V, Franklin J, Pfreundschuh M , et al. the German Hodgkin’s Lymphoma Study Group. Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin’s Disease . N. Engl. J. Med., 2003;348(24):2386–95.
  • 14 Gobbi PG, Levis A, Chisesi T, et al. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin’s lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. J Clin Oncol. 2005;20;23(36):9198-207.
  • 15 Laskar S, Gupta T, Vimal S,Consolidation radiation after complete remission in Hodgkin’s disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy:is there a need? J Clin Oncol. 2004;1:22(1):62-8.